ramatroban

Small molecule

KKARE Biosciences

ramatroban is one of 48 small molecule programs targeting Pneumonia. It is currently in development.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

AsthmaActive, not recruiting

PneumoniaPhase 2/Phase 3

Active, not recruiting

AsthmaPhase 2/Phase 3

Active, not recruiting

Competition

Competitive Landscape

1051 competitors in Asthma

#DrugCompanyPhaseTrials

Veramyst

GSK

Preclinical

46 2

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

35 3

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 4

Asmanex

Novartis

Preclinical

5 5

Celexa

AbbVie

Preclinical

1 6

Arcoxia

Atrovent

2 8

Decadron

QQuince Therapeutics S.p.A.

Preclinical

1 9

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

1 10

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Pneumonia1 trial

Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

Recruiting·KKARE Biosciences·Phase 2/3·NCT05706454·324 enrolled

Asthma1 trial

Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite

Withdrawn·RResearch Center Borstel·Phase 2/3·NCT00311051

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for ramatroban. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ramatroban compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ramatroban. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — KARE Biosciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Company: KKARE Biosciences

ramatroban

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Pneumonia1 trial

Asthma1 trial

References

Drug Info

Quick Facts

Related News